![Edward Swabb](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edward Swabb
Geen lopende functies
Profiel
Edward Swabb worked as a Director of Clinical Research at Pharmacia Corp.
He then worked as the Chief Medical Officer and SVP of Drug Development at Myrexis, Inc. from 2009 to 2010.
Swabb received his undergraduate and doctorate degrees from the University of Pennsylvania and his undergraduate degree from Vanderbilt University.
He also received his graduate and doctorate degrees from the University of Delaware.
Eerdere bekende functies van Edward Swabb
Bedrijven | Functie | Einde |
---|---|---|
MYREXIS, INC. | Hoofd Techniek/Wetenschap/O&O | 18-06-2010 |
Pharmacia Corp.
![]() Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Edward Swabb
University of Pennsylvania | Doctorate Degree |
University of Delaware | Doctorate Degree |
Vanderbilt University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MYREXIS, INC. | Finance |
Bedrijven in privébezit | 1 |
---|---|
Pharmacia Corp.
![]() Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |